search
Back to results

Bi-PAP vs Sham Bi-PAP on Pulmonary Function in Morbidly Obese Patients After Bariatric Surgery

Primary Purpose

Atelectasis, Pulmonary Infection, Chronic Obstructive Pulmonary Disease (COPD)

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Bi-PAP
Sham Bi-PAP
Sponsored by
Evangelismos Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atelectasis focused on measuring Bi-PAP, BiPAP, morbid obesity, anesthesia, bariatric surgery, sham Bi-PAP, sham BiPAP, postoperative complications

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All patients have been Morbidly Obese (BMI> 40kg/m2) for at least 10 years
  • All patients had unsuccessfully tried to lose weight by other non-invasive means.
  • All patients enrolled were continuous positive airway pressure (CPAP) and Bi-PAP naïve and had no knowledge about the Bi-PAP apparatus prior to enrollment
  • All patients underwent OBS (gastroplasty by Mason or gastric bypass) by the same operating team
  • All patients were treated with the same standard anesthetic protocol

Exclusion Criteria:

  • Cardiovascular and pulmonary disease not related to obesity status
  • Chronic renal disease
  • Patients who were initially enrolled but did not use the allocated device (Bi-PAP or Sham Bi-PAP) for at least 12 h daily were also excluded at a later point.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Sham Comparator

    Active Comparator

    Arm Label

    Sham Bi-PAP

    Bi-PAP

    Arm Description

    Sham Bi-PAP was applied through nasal mask for 3 days postoperatively. Sham Bi-PAP was created by introducing a "hole" at the connection of the mask with the spiral tube of Bi-PAP. With this modality, also used on previous studies, the applied pressure by sham Bi-PAP was constant and equal to 2 centimeter of water (cm H2O).

    Bi-PAP through nasal mask, at individualized IPAP/EPAP pressures, was applied for 3 days postoperatively. IPAP and EPAP in the Bi-PAP system were individualized for each patient in accordance with accepted values of SpO2, PaCO2, and patient synchronization and tolerability with the device.Individualized setting of pressures in patient group was applied gradually starting with 12/4 cm H2O (IPAP/EPAP) and up to 18/10 (IPAP/EPAP) with consecutive increases of 2 cm H2O.

    Outcomes

    Primary Outcome Measures

    Forced Expiratory Volume at One Second (FEV1) Difference
    difference in FEV1 value measured by spirometry pre- and post-operatively
    Forced Vital Capacity (FVC) Difference
    difference in FVC value measured by spirometry pre- and post-operatively
    Peak Expiratory Flow Rate (PEFR) Difference
    difference in PEFR value measured by spirometry pre- and post-operatively
    SpO2 Difference
    difference in SpO2 value measured by spirometry pre- and post-operatively
    Number of Participants With Hypoxemia
    occurrence of hypoxemia, considered as SpO2<90%, post-operatively
    Number of Participants With Atelectasis
    occurrence of atelectasis as defined by chest X-ray (CXR) post-operatively with CXR before surgery as baseline

    Secondary Outcome Measures

    Post-operative Pain
    Intensity of pain was assessed post-operatively by Numerical Rating Scale (NRS) (0-10, 0=no pain, 10=worst pain imaginable)
    Days of Hospitalization
    duration of hospitalization, calculated by discharge date minus admission date

    Full Information

    First Posted
    February 5, 2018
    Last Updated
    November 25, 2020
    Sponsor
    Evangelismos Hospital
    Collaborators
    Elpis General Hospital, Sotiria General Hospital, Evgenidion Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03438383
    Brief Title
    Bi-PAP vs Sham Bi-PAP on Pulmonary Function in Morbidly Obese Patients After Bariatric Surgery
    Official Title
    The Effect of Bi-PAP at Individualized Pressures on the Postoperative Pulmonary Recovery of Morbidly Obese Patients (MOP) Undergoing Open Bariatric Surgery (OBS) and Possible Placebo Device-related Effects (Sham-Bi-PAP)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2020
    Overall Recruitment Status
    Completed
    Study Start Date
    May 23, 2011 (Actual)
    Primary Completion Date
    May 22, 2012 (Actual)
    Study Completion Date
    May 31, 2012 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Evangelismos Hospital
    Collaborators
    Elpis General Hospital, Sotiria General Hospital, Evgenidion Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    Yes
    Product Manufactured in and Exported from the U.S.
    Yes
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The effect of biphasic positive airway pressure (Bi-PAP) at individualized pressures on the postoperative pulmonary recovery of morbidly obese patients (MOP) undergoing open bariatric surgery (OBS) and possible placebo device-related effects (sham-Bi-PAP) were investigated.
    Detailed Description
    In the present study the effect of Bi-PAP on the postoperative respiratory function and related complications of MOP undergoing OBS through a randomized sham-controlled design was investigated. Bi-PAP was applied at individualized pressures in order to optimize respiratory support and sham Bi-PAP was also used in order to neutralize possible placebo device related effect and researcher related bias. The investigators hypothesized that the use of Bi-PAP at individualized pressures in MOP undergoing OBS, ameliorates postoperative respiratory function as well as diminishes related pulmonary complications, postoperative pain and duration of hospitalization. Primary endpoints were the difference in pre- and postoperative measurements of certain pulmonary function parameters (forced expiratory volume at one second (FEV1), forced vital capacity (FVC), peak expiratory flow rate (PEFR) and oxygen saturation by pulse oximetry (SpO2) and the incidence of certain pulmonary complications postoperatively (hypoxemia, atelectasis, lower respiratory tract infections). Secondary endpoints were postoperative pain and days of hospitalization.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Atelectasis, Pulmonary Infection, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Disease, Hypoxemic Respiratory Failure, Hypoxemia, Morbid Obesity
    Keywords
    Bi-PAP, BiPAP, morbid obesity, anesthesia, bariatric surgery, sham Bi-PAP, sham BiPAP, postoperative complications

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Patients were assigned into the following two study groups postoperatively: Sham Bi-PAP (control group) group in which sham Bi-PAP was applied through nasal mask for 3 days postoperatively. Bi-PAP group in which Bi-PAP through nasal mask, at individualized IPAP/EPAP pressures, was applied for 3 days postoperatively. 1 patient was initially enrolled in the protocol but was excluded from the participant flow design because of recent onset of cardiovascular disease (CAD).
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    48 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Sham Bi-PAP
    Arm Type
    Sham Comparator
    Arm Description
    Sham Bi-PAP was applied through nasal mask for 3 days postoperatively. Sham Bi-PAP was created by introducing a "hole" at the connection of the mask with the spiral tube of Bi-PAP. With this modality, also used on previous studies, the applied pressure by sham Bi-PAP was constant and equal to 2 centimeter of water (cm H2O).
    Arm Title
    Bi-PAP
    Arm Type
    Active Comparator
    Arm Description
    Bi-PAP through nasal mask, at individualized IPAP/EPAP pressures, was applied for 3 days postoperatively. IPAP and EPAP in the Bi-PAP system were individualized for each patient in accordance with accepted values of SpO2, PaCO2, and patient synchronization and tolerability with the device.Individualized setting of pressures in patient group was applied gradually starting with 12/4 cm H2O (IPAP/EPAP) and up to 18/10 (IPAP/EPAP) with consecutive increases of 2 cm H2O.
    Intervention Type
    Device
    Intervention Name(s)
    Bi-PAP
    Intervention Description
    The Bi-PAP system combines inspiratory support-IPAP (inspiratory positive airway pressure) with expiratory support-EPAP (expiratory positive airway pressure) and has been used, with good results, in a number of different clinical conditions such as COPD, respiratory failure due to neuromuscular disease, cardiogenic pulmonary edema and immediately post-operatively with pro-phylactic purpose.
    Intervention Type
    Device
    Intervention Name(s)
    Sham Bi-PAP
    Intervention Description
    Sham Bi-PAP was created by introducing a "hole" at the connection of the mask with the spiral tube of the conventional Bi-PAP system. By doing so, the applied pressure by sham Bi-PAP was constant and equal to 2 cm H2O.
    Primary Outcome Measure Information:
    Title
    Forced Expiratory Volume at One Second (FEV1) Difference
    Description
    difference in FEV1 value measured by spirometry pre- and post-operatively
    Time Frame
    24 h before surgery and at 24, 48 and 72 h post-operatively
    Title
    Forced Vital Capacity (FVC) Difference
    Description
    difference in FVC value measured by spirometry pre- and post-operatively
    Time Frame
    24 h before surgery and at 24, 48 and 72 hours post-operatively
    Title
    Peak Expiratory Flow Rate (PEFR) Difference
    Description
    difference in PEFR value measured by spirometry pre- and post-operatively
    Time Frame
    24 h before surgery and at 24, 48 and 72 hours post-operatively
    Title
    SpO2 Difference
    Description
    difference in SpO2 value measured by spirometry pre- and post-operatively
    Time Frame
    24 h before surgery and at 24, 48 and 72 hours post-operatively
    Title
    Number of Participants With Hypoxemia
    Description
    occurrence of hypoxemia, considered as SpO2<90%, post-operatively
    Time Frame
    At 24, 48 and 72 hours post-operatively
    Title
    Number of Participants With Atelectasis
    Description
    occurrence of atelectasis as defined by chest X-ray (CXR) post-operatively with CXR before surgery as baseline
    Time Frame
    At 24, 48 and 72 hours post-operatively
    Secondary Outcome Measure Information:
    Title
    Post-operative Pain
    Description
    Intensity of pain was assessed post-operatively by Numerical Rating Scale (NRS) (0-10, 0=no pain, 10=worst pain imaginable)
    Time Frame
    right before spirometry, at 24, 48 and 72 h post-operatively
    Title
    Days of Hospitalization
    Description
    duration of hospitalization, calculated by discharge date minus admission date
    Time Frame
    From day of admission to day of discharge from the hospital

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: All patients have been Morbidly Obese (BMI> 40kg/m2) for at least 10 years All patients had unsuccessfully tried to lose weight by other non-invasive means. All patients enrolled were continuous positive airway pressure (CPAP) and Bi-PAP naïve and had no knowledge about the Bi-PAP apparatus prior to enrollment All patients underwent OBS (gastroplasty by Mason or gastric bypass) by the same operating team All patients were treated with the same standard anesthetic protocol Exclusion Criteria: Cardiovascular and pulmonary disease not related to obesity status Chronic renal disease Patients who were initially enrolled but did not use the allocated device (Bi-PAP or Sham Bi-PAP) for at least 12 h daily were also excluded at a later point.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Konstantinos Louis, MD, PhD
    Organizational Affiliation
    Dpt of ObGyn, Konstantopoulio-Patision Hospital, Greece
    Official's Role
    Study Director
    First Name & Middle Initial & Last Name & Degree
    Konstantinos Roditis, MD, MSc
    Organizational Affiliation
    Dpt of Vascular Surgery, Korgialenio-Benakio HRC Hospital, Greece
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Aikaterini N. Alexandropoulou, MD, PhD
    Organizational Affiliation
    Anaesthesiology Dpt, Evangelismos Hospital, Greece
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    16779465
    Citation
    Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J. 2006 May-Jun;13(4):203-10. doi: 10.1155/2006/834786.
    Results Reference
    background
    PubMed Identifier
    19875713
    Citation
    Salome CM, King GG, Berend N. Physiology of obesity and effects on lung function. J Appl Physiol (1985). 2010 Jan;108(1):206-11. doi: 10.1152/japplphysiol.00694.2009. Epub 2009 Oct 29.
    Results Reference
    background
    PubMed Identifier
    20822992
    Citation
    Gifford AH, Leiter JC, Manning HL. Respiratory function in an obese patient with sleep-disordered breathing. Chest. 2010 Sep;138(3):704-15. doi: 10.1378/chest.09-3030. No abstract available.
    Results Reference
    background
    PubMed Identifier
    22040049
    Citation
    Littleton SW. Impact of obesity on respiratory function. Respirology. 2012 Jan;17(1):43-9. doi: 10.1111/j.1440-1843.2011.02096.x.
    Results Reference
    background
    PubMed Identifier
    19961114
    Citation
    Hans GA, Lauwick S, Kaba A, Brichant JF, Joris JL. Postoperative respiratory problems in morbidly obese patients. Acta Anaesthesiol Belg. 2009;60(3):169-75.
    Results Reference
    background
    PubMed Identifier
    8797421
    Citation
    Lawrence VA, Dhanda R, Hilsenbeck SG, Page CP. Risk of pulmonary complications after elective abdominal surgery. Chest. 1996 Sep;110(3):744-50. doi: 10.1378/chest.110.3.744.
    Results Reference
    background
    PubMed Identifier
    6638679
    Citation
    Simonneau G, Vivien A, Sartene R, Kunstlinger F, Samii K, Noviant Y, Duroux P. Diaphragm dysfunction induced by upper abdominal surgery. Role of postoperative pain. Am Rev Respir Dis. 1983 Nov;128(5):899-903. doi: 10.1164/arrd.1983.128.5.899.
    Results Reference
    background
    PubMed Identifier
    10764336
    Citation
    Vassilakopoulos T, Mastora Z, Katsaounou P, Doukas G, Klimopoulos S, Roussos C, Zakynthinos S. Contribution of pain to inspiratory muscle dysfunction after upper abdominal surgery: A randomized controlled trial. Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1372-5. doi: 10.1164/ajrccm.161.4.9907082.
    Results Reference
    background
    PubMed Identifier
    20608558
    Citation
    Pelosi P, Gregoretti C. Perioperative management of obese patients. Best Pract Res Clin Anaesthesiol. 2010 Jun;24(2):211-25. doi: 10.1016/j.bpa.2010.02.001.
    Results Reference
    background
    PubMed Identifier
    11573670
    Citation
    Loadsman JA, Hillman DR. Anaesthesia and sleep apnoea. Br J Anaesth. 2001 Feb;86(2):254-66. doi: 10.1093/bja/86.2.254.
    Results Reference
    background
    PubMed Identifier
    22833138
    Citation
    Cullen A, Ferguson A. Perioperative management of the severely obese patient: a selective pathophysiological review. Can J Anaesth. 2012 Oct;59(10):974-96. doi: 10.1007/s12630-012-9760-2. Epub 2012 Jul 26.
    Results Reference
    background
    PubMed Identifier
    15809132
    Citation
    Casati A, Putzu M. Anesthesia in the obese patient: pharmacokinetic considerations. J Clin Anesth. 2005 Mar;17(2):134-45. doi: 10.1016/j.jclinane.2004.01.009.
    Results Reference
    background
    PubMed Identifier
    10733789
    Citation
    Kyzer S, Ramadan E, Gersch M, Chaimoff C. Patient-Controlled Analgesia Following Vertical Gastroplasty: a Comparison with Intramuscular Narcotics. Obes Surg. 1995 Feb;5(1):18-21. doi: 10.1381/096089295765558097.
    Results Reference
    background
    PubMed Identifier
    12944441
    Citation
    Charghi R, Backman S, Christou N, Rouah F, Schricker T. Patient controlled i.v. analgesia is an acceptable pain management strategy in morbidly obese patients undergoing gastric bypass surgery. A retrospective comparison with epidural analgesia. Can J Anaesth. 2003 Aug-Sep;50(7):672-8. doi: 10.1007/BF03018709.
    Results Reference
    background
    PubMed Identifier
    11294404
    Citation
    Nguyen NT, Lee SL, Goldman C, Fleming N, Arango A, McFall R, Wolfe BM. Comparison of pulmonary function and postoperative pain after laparoscopic versus open gastric bypass: a randomized trial. J Am Coll Surg. 2001 Apr;192(4):469-76; discussion 476-7. doi: 10.1016/s1072-7515(01)00822-5.
    Results Reference
    background
    PubMed Identifier
    8265725
    Citation
    Thomas JA, McIntosh JM. Are incentive spirometry, intermittent positive pressure breathing, and deep breathing exercises effective in the prevention of postoperative pulmonary complications after upper abdominal surgery? A systematic overview and meta-analysis. Phys Ther. 1994 Jan;74(1):3-10; discussion 10-6. doi: 10.1093/ptj/74.1.3.
    Results Reference
    background
    PubMed Identifier
    20608563
    Citation
    Ambrosino N, Gabbrielli L. Physiotherapy in the perioperative period. Best Pract Res Clin Anaesthesiol. 2010 Jun;24(2):283-9. doi: 10.1016/j.bpa.2010.02.003.
    Results Reference
    background
    PubMed Identifier
    11179136
    Citation
    Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med. 2001 Feb;163(2):540-77. doi: 10.1164/ajrccm.163.2.9906116. No abstract available.
    Results Reference
    background
    PubMed Identifier
    20019602
    Citation
    Pelosi P, Jaber S. Noninvasive respiratory support in the perioperative period. Curr Opin Anaesthesiol. 2010 Apr;23(2):233-8. doi: 10.1097/ACO.0b013e328335daec.
    Results Reference
    background
    PubMed Identifier
    8162724
    Citation
    Renston JP, DiMarco AF, Supinski GS. Respiratory muscle rest using nasal BiPAP ventilation in patients with stable severe COPD. Chest. 1994 Apr;105(4):1053-60. doi: 10.1378/chest.105.4.1053.
    Results Reference
    background
    PubMed Identifier
    23543531
    Citation
    Radunovic A, Annane D, Rafiq MK, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2013 Mar 28;(3):CD004427. doi: 10.1002/14651858.CD004427.pub3.
    Results Reference
    background
    PubMed Identifier
    12958051
    Citation
    Nava S, Carbone G, DiBattista N, Bellone A, Baiardi P, Cosentini R, Marenco M, Giostra F, Borasi G, Groff P. Noninvasive ventilation in cardiogenic pulmonary edema: a multicenter randomized trial. Am J Respir Crit Care Med. 2003 Dec 15;168(12):1432-7. doi: 10.1164/rccm.200211-1270OC. Epub 2003 Sep 4.
    Results Reference
    background
    PubMed Identifier
    17764785
    Citation
    Moritz F, Brousse B, Gellee B, Chajara A, L'Her E, Hellot MF, Benichou J. Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial. Ann Emerg Med. 2007 Dec;50(6):666-75, 675.e1. doi: 10.1016/j.annemergmed.2007.06.488. Epub 2007 Aug 30.
    Results Reference
    background
    PubMed Identifier
    8986484
    Citation
    Gust R, Gottschalk A, Schmidt H, Bottiger BW, Bohrer H, Martin E. Effects of continuous (CPAP) and bi-level positive airway pressure (BiPAP) on extravascular lung water after extubation of the trachea in patients following coronary artery bypass grafting. Intensive Care Med. 1996 Dec;22(12):1345-50. doi: 10.1007/BF01709549.
    Results Reference
    background
    PubMed Identifier
    9228366
    Citation
    Aguilo R, Togores B, Pons S, Rubi M, Barbe F, Agusti AG. Noninvasive ventilatory support after lung resectional surgery. Chest. 1997 Jul;112(1):117-21. doi: 10.1378/chest.112.1.117.
    Results Reference
    background
    PubMed Identifier
    9118706
    Citation
    Joris JL, Sottiaux TM, Chiche JD, Desaive CJ, Lamy ML. Effect of bi-level positive airway pressure (BiPAP) nasal ventilation on the postoperative pulmonary restrictive syndrome in obese patients undergoing gastroplasty. Chest. 1997 Mar;111(3):665-70. doi: 10.1378/chest.111.3.665.
    Results Reference
    background
    PubMed Identifier
    12243311
    Citation
    Ebeo CT, Benotti PN, Byrd RP Jr, Elmaghraby Z, Lui J. The effect of bi-level positive airway pressure on postoperative pulmonary function following gastric surgery for obesity. Respir Med. 2002 Sep;96(9):672-6. doi: 10.1053/rmed.2002.1357.
    Results Reference
    background
    PubMed Identifier
    12684289
    Citation
    Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest. 2003 Apr;123(4):1018-25. doi: 10.1378/chest.123.4.1018.
    Results Reference
    background
    PubMed Identifier
    12358327
    Citation
    Thys F, Roeseler J, Reynaert M, Liistro G, Rodenstein DO. Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo-controlled trial. Eur Respir J. 2002 Sep;20(3):545-55. doi: 10.1183/09031936.02.00287402.
    Results Reference
    background
    PubMed Identifier
    8202099
    Citation
    Crapo RO. Pulmonary-function testing. N Engl J Med. 1994 Jul 7;331(1):25-30. doi: 10.1056/NEJM199407073310107. No abstract available.
    Results Reference
    background
    PubMed Identifier
    20354010
    Citation
    Lumb AB, Greenhill SJ, Simpson MP, Stewart J. Lung recruitment and positive airway pressure before extubation does not improve oxygenation in the post-anaesthesia care unit: a randomized clinical trial. Br J Anaesth. 2010 May;104(5):643-7. doi: 10.1093/bja/aeq080. Epub 2010 Mar 30.
    Results Reference
    background
    PubMed Identifier
    19293693
    Citation
    Neligan PJ, Malhotra G, Fraser M, Williams N, Greenblatt EP, Cereda M, Ochroch EA. Continuous positive airway pressure via the Boussignac system immediately after extubation improves lung function in morbidly obese patients with obstructive sleep apnea undergoing laparoscopic bariatric surgery. Anesthesiology. 2009 Apr;110(4):878-84. doi: 10.1097/ALN.0b013e31819b5d8c.
    Results Reference
    background
    PubMed Identifier
    21465320
    Citation
    Wong DT, Adly E, Ip HY, Thapar S, Maxted GR, Chung FF. A comparison between the Boussignac continuous positive airway pressure mask and the venturi mask in terms of improvement in the PaO2/F(I)O2 ratio in morbidly obese patients undergoing bariatric surgery: a randomized controlled trial. Can J Anaesth. 2011 Jun;58(6):532-9. doi: 10.1007/s12630-011-9497-3. Epub 2011 Apr 5.
    Results Reference
    background
    PubMed Identifier
    22567762
    Citation
    Cobbold A, Lord S. Treatment and management of obesity: is surgical intervention the answer? J Perioper Pract. 2012 Apr;22(4):114-21. doi: 10.1177/175045891202200404.
    Results Reference
    background
    PubMed Identifier
    19843790
    Citation
    Talab HF, Zabani IA, Abdelrahman HS, Bukhari WL, Mamoun I, Ashour MA, Sadeq BB, El Sayed SI. Intraoperative ventilatory strategies for prevention of pulmonary atelectasis in obese patients undergoing laparoscopic bariatric surgery. Anesth Analg. 2009 Nov;109(5):1511-6. doi: 10.1213/ANE.0b013e3181ba7945.
    Results Reference
    background
    PubMed Identifier
    12456460
    Citation
    Eichenberger A, Proietti S, Wicky S, Frascarolo P, Suter M, Spahn DR, Magnusson L. Morbid obesity and postoperative pulmonary atelectasis: an underestimated problem. Anesth Analg. 2002 Dec;95(6):1788-92, table of contents. doi: 10.1097/00000539-200212000-00060.
    Results Reference
    background
    PubMed Identifier
    19640798
    Citation
    Ramirez A, Lalor PF, Szomstein S, Rosenthal RJ. Continuous positive airway pressure in immediate postoperative period after laparoscopic Roux-en-Y gastric bypass: is it safe? Surg Obes Relat Dis. 2009 Sep-Oct;5(5):544-6. doi: 10.1016/j.soard.2009.05.007. Epub 2009 Jun 23.
    Results Reference
    background
    PubMed Identifier
    15018761
    Citation
    Vasquez TL, Hoddinott K. A potential complication of bi-level positive airway pressure after gastric bypass surgery. Obes Surg. 2004 Feb;14(2):282-4. doi: 10.1381/096089204322857717.
    Results Reference
    background
    PubMed Identifier
    12022987
    Citation
    Huerta S, DeShields S, Shpiner R, Li Z, Liu C, Sawicki M, Arteaga J, Livingston EH. Safety and efficacy of postoperative continuous positive airway pressure to prevent pulmonary complications after Roux-en-Y gastric bypass. J Gastrointest Surg. 2002 May-Jun;6(3):354-8. doi: 10.1016/s1091-255x(01)00048-8.
    Results Reference
    background
    PubMed Identifier
    31268268
    Citation
    Alexandropoulou AN, Louis K, Papakonstantinou A, Tzirogiannis K, Stamataki E, Roussos C, Alchanatis M, Gratziou C, Vagiakis E, Roditis K. The influence of biphasic positive airway pressure vs. sham biphasic positive airway pressure on pulmonary function in morbidly obese patients after bariatric surgery. Anaesthesiol Intensive Ther. 2019;51(2):88-95. doi: 10.5114/ait.2019.85868.
    Results Reference
    result
    Links:
    URL
    https://www.termedia.pl/Journal/-118/pdf-36902-10?filename=The%20influence%20of%20biphasic.pdf
    Description
    Publication of Study Results

    Learn more about this trial

    Bi-PAP vs Sham Bi-PAP on Pulmonary Function in Morbidly Obese Patients After Bariatric Surgery

    We'll reach out to this number within 24 hrs